Building Global Capacity to Conduct Pathology-Based Postmortem Examination: Establishing a New Training Hub for Minimally Invasive Tissue Sampling.
capacity building
low- and middle-income countries
minimally invasive tissue sampling
mortality surveillance
training
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
15 12 2021
15 12 2021
Historique:
entrez:
15
12
2021
pubmed:
16
12
2021
medline:
16
3
2022
Statut:
ppublish
Résumé
Minimally invasive tissue sampling (MITS), an alternative to complete diagnostic autopsy, is a pathology-based postmortem examination that has been validated in low- and middle-income countries (LMICs) and can provide accurate cause of death information when used with other data. The MITS Surveillance Alliance was established in 2017 with the goal to expand MITS globally by increasing training capacity, accessibility, and availability in LMICs. Between January 2019 and May 2020, the MITS Surveillance Alliance convened a multidisciplinary team of technical advisors to attain this goal. This article describes the process used to develop criteria and identify an optimal location for a MITS training hub, establish a cadre of LMIC-based trainers, refine standardized MITS sample collection protocols, develop a training program, and release a telepathology platform for quality assessment of MITS histological samples. Results include the creation of a training hub and curriculum, with a total of 9 pathologists and technicians trained as part of the training of the trainers. Those trainers trained 15 participants from seven MITS projects representing 6 LMICs trained in MITS sample collection. The 15 participants have gone on to train more than 50 project-level staff in MITS sample collection. Lessons learned include an appreciation for using an iterative process for establishing standardized procedures, creating opportunities for all stakeholders to deliver critical feedback, and highlighting the importance of complementing in-person trainings with ongoing technical assistance.
Sections du résumé
BACKGROUND
Minimally invasive tissue sampling (MITS), an alternative to complete diagnostic autopsy, is a pathology-based postmortem examination that has been validated in low- and middle-income countries (LMICs) and can provide accurate cause of death information when used with other data. The MITS Surveillance Alliance was established in 2017 with the goal to expand MITS globally by increasing training capacity, accessibility, and availability in LMICs. Between January 2019 and May 2020, the MITS Surveillance Alliance convened a multidisciplinary team of technical advisors to attain this goal.
METHODS
This article describes the process used to develop criteria and identify an optimal location for a MITS training hub, establish a cadre of LMIC-based trainers, refine standardized MITS sample collection protocols, develop a training program, and release a telepathology platform for quality assessment of MITS histological samples.
RESULTS
Results include the creation of a training hub and curriculum, with a total of 9 pathologists and technicians trained as part of the training of the trainers. Those trainers trained 15 participants from seven MITS projects representing 6 LMICs trained in MITS sample collection. The 15 participants have gone on to train more than 50 project-level staff in MITS sample collection.
CONCLUSIONS
Lessons learned include an appreciation for using an iterative process for establishing standardized procedures, creating opportunities for all stakeholders to deliver critical feedback, and highlighting the importance of complementing in-person trainings with ongoing technical assistance.
Identifiants
pubmed: 34910179
pii: 6460381
doi: 10.1093/cid/ciab765
pmc: PMC8672740
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S390-S395Subventions
Organisme : Bill and Melinda Gates Foundation
ID : OPP1180554
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Glob Health Action. 2020 Dec 31;13(1):1792682
pubmed: 32713325
Lancet. 2018 May 12;391(10133):1953-1964
pubmed: 29550030
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S302-S310
pubmed: 31598667
BMC Med. 2014 Feb 04;12:19
pubmed: 24495839
PLoS One. 2015 Jun 30;10(6):e0132057
pubmed: 26126191
JMIR Res Protoc. 2019 Jan 10;8(1):e10854
pubmed: 30632968
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S322-S332
pubmed: 31598668
Reprod Health. 2018 Jun 22;15(Suppl 1):89
pubmed: 29945651
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S257-S259
pubmed: 31598658